from the global experience with mitoxantrone , it seems that for patients who have not previously received anthracycline therapy , the risk of congestive heart failure is minimal up to a cumulative mitoxantrone dose of 160 mg/m2 .
C0018802
congestive heart failure
C0026259
mitoxantrone